Several studies provide evidence that cross-linking of CD137 on T cells either

with its naturally occurring ligand (CD137L) or by agonistic anti-CD137 monoclonal antibody (mAb) exerts various forms of immune activation both in vitro and in vivo[7–10]. In-vivo stimulation of CD137 resulted in rejection of INCB024360 tumours [11,12], cardiac allograft and skin transplants [13,14], inhibition of graft-versus-host disease (GVHD) [15] or autoimmune responses [16,17] and promotion of viral defence [18]. After the generation of CD137-deficient (CD137−/−) mice, the role of the CD137/CD137L pathway in T cell immunity was studied further [19]. T cells derived from CD137−/− mice showed

enhanced proliferation, whereas their capacity for secretion of cytokines interleukin (IL)-2, IL-4 and interferon (IFN)-γ was diminished [19]. The frequency and function of NK and NK T cells was reduced in CD137−/− mice. However, the influence of CD137 deficiency on maturation or steady-state CD4+ and CD8+ T cell populations has not yet been reported [20]. So far, CD137−/− mice have not been analysed in allergic airway disease models. In this regard, we and others have shown a critical role of CD137 in the immune response of allergic asthma [21–23]. Stimulation with agonistic anti-CD137 mAb not only prevented, but even reversed the complete asthma phenotype mediated partly by IFN-γ-producing CD8+ T cells [21]. In the present study, we followed a contrasting

approach and investigated Florfenicol the effect of CD137 deficiency https://www.selleckchem.com/products/E7080.html in the same OVA-based asthma model published previously [21] by comparative analysis of CD137−/− and wild-type (WT) mice. We were further interested in whether the absence of CD137 influences the establishment of respiratory tolerance, because several co-stimulatory molecules, including CD134 (OX-40), cytotoxic T lymphocyte antigen (CTLA)-4 and inducible co-stimulator (ICOS), have been shown to play a role in regulatory T cell (Treg) function and are thus implicated to be involved in the development and maintenance of tolerance [24,25]. CD137 is expressed constitutively on murine Tregs, whereas in humans CD137 is up-regulated rapidly on natural and inducible Tregs. The exact importance of CD137 in Tregs remains controversial, but an increasing body of evidence points towards a critical role for Treg expansion, survival and function [24,26,27]. However, so far the role of CD137/CD137L pathway in the context of development and maintenance of respiratory tolerance is uncertain. Therefore, aside from the classical OVA-based sensitization and challenge protocol, we compared WT and CD137−/− mice which were additionally tolerized with OVA prior to sensitization.